David A. Siegel T2 Biosystems, Inc. Transaction History

Two Sigma Advisers, LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$1.04 - $1.69 $227,968 - $370,448	-219,200 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$1.32 - $3.79 $289,344 - $830,768	219,200 New	219,200 $355,000
Q4 2018 Feb 14, 2019	SELL	$2.98 - $6.86 $97,744 - $225,008	-32,800 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$5.36 - $7.83 $46,632 - $68,121	-8,700 Reduced 20.96%	32,800 $244,000
Q2 2018 Aug 14, 2018	BUY	$5.97 - $9.58 $247,755 - $397,570	41,500 New	41,500 $321,000

Ticker TTOO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 7,050,850
Market Cap $3.17M
Description
T2 Biosystems, Inc., an in vitro diagnostics company, develops diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fl...

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.